Microarray analysis of bone marrow-derived macrophage cells treated with Kdo₂-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios KEGG pathway: Lysosome (mmu04142) Legend: : View data/graphs for replicates Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr AK088507 KLA  ATP  ATP+KLA AK088507 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430019C06 product:unclassifiable, full insert sequence [AK088507] KLA .98 .96 .97 1.01 .99 .98 1.10 ATP .96 1.00 1.06 1.04 1.09 .95 1.02 KLA/ATP 1.02 1.02 1.02 .95 1.00 1.01 1.03 AK209324 KLA  ATP  ATP+KLA AK209324 cDNA, clone:Y2G0114L23, strand:plus, reference:ENSEMBL:Mouse-Transcript-ENST:ENSMUST00000060207, based on BLAT search. [AK209324] KLA .48 .51 .55 .57 .80 .90 1.17 ATP 1.01 .96 .73 .60 .76 .78 1.24 KLA/ATP .54 .46 .42 .54 .76 .76 .73 Abca2 KLA  ATP  ATP+KLA NM_007379 ATP-binding cassette, sub-family A (ABC1), member 2 (Abca2), mRNA [NM_007379] KLA .78 .80 .77 .59 .57 .44 .54 ATP 1.11 1.27 .82 1.16 .74 .49 .69 KLA/ATP .94 .92 .60 .73 .53 .42 .43 Abcb9 KLA  ATP  ATP+KLA NM_019875 ATP-binding cassette, sub-family B (MDR/TAP), member 9 (Abcb9), mRNA [NM_019875] KLA .74 .72 .72 .95 .90 .86 .78 ATP 1.05 .90 1.25 .96 1.00 .84 .66 KLA/ATP .80 .76 1.02 .73 .90 .80 .93 Acp2 KLA  ATP  ATP+KLA AK170658 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630113A07 product:acid phosphatase 2, lysosomal, full insert sequence [AK170658] KLA 1.17 1.24 1.33 1.51 2.46 3.34 3.43 ATP .95 .99 .76 1.07 .73 .56 .97 KLA/ATP 1.23 1.23 .78 1.06 .72 .78 2.19 Acp2 KLA  ATP  ATP+KLA NM_007387 acid phosphatase 2, lysosomal (Acp2), mRNA [NM_007387] KLA 1.52 1.61 1.73 1.82 2.82 4.19 5.68 ATP 1.12 1.21 .95 1.29 .87 .76 2.68 KLA/ATP 1.81 1.80 1.24 1.72 1.04 1.16 5.43 Acp5 KLA  ATP  ATP+KLA NM_007388 acid phosphatase 5, tartrate resistant (Acp5), transcript variant 3, mRNA [NM_007388] KLA 3.62 3.55 3.27 3.26 3.31 3.93 5.79 ATP .96 1.00 1.29 1.96 2.30 3.05 3.81 KLA/ATP 3.61 3.85 4.05 5.38 4.56 5.15 6.77 Aga KLA  ATP  ATP+KLA NM_001005847 aspartylglucosaminidase (Aga), mRNA [NM_001005847] KLA 1.07 1.08 1.08 1.01 1.02 .98 1.30 ATP 1.12 1.12 1.21 1.26 1.14 .91 1.51 KLA/ATP 1.02 1.11 1.21 1.29 .94 .85 .94 Ap1b1 KLA  ATP  ATP+KLA NM_007454 adaptor protein complex AP-1, beta 1 subunit (Ap1b1), mRNA [NM_007454] KLA .55 .50 .49 .47 .40 .52 .32 ATP 1.01 .88 1.06 .70 .45 .19 .90 KLA/ATP .53 .48 .64 .43 .33 .18 .20 Ap1g1 KLA  ATP  ATP+KLA NM_009677 adaptor protein complex AP-1, gamma 1 subunit (Ap1g1), mRNA [NM_009677] KLA 1.47 1.45 1.66 1.73 1.92 1.67 1.81 ATP 1.13 1.07 .77 .86 .90 1.56 1.65 KLA/ATP 1.46 1.45 1.03 1.10 .94 1.73 2.39 Ap1g2 KLA  ATP  ATP+KLA NM_007455 adaptor protein complex AP-1, gamma 2 subunit (Ap1g2), transcript variant 1, mRNA [NM_007455] KLA 1.32 1.23 1.25 1.42 1.44 .99 1.11 ATP 1.21 1.10 1.03 1.15 .98 .81 .75 KLA/ATP 1.38 1.43 1.40 1.47 1.09 .86 .88 Ap1m1 KLA  ATP  ATP+KLA NM_007456 adaptor-related protein complex AP-1, mu subunit 1 (Ap1m1), mRNA [NM_007456] KLA .90 .93 .98 .96 1.08 1.11 1.04 ATP 1.00 1.06 .90 1.12 .91 .86 1.07 KLA/ATP .95 .99 .80 1.00 .84 .82 .97 Ap1m2 KLA  ATP  ATP+KLA AK082674 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230082G12 product:adaptor protein complex AP-1, mu 2 subunit, full insert sequence [AK082674] KLA 1.03 1.02 1.06 .96 1.02 1.03 1.06 ATP .95 1.02 .99 1.05 1.04 1.04 1.07 KLA/ATP 1.00 .98 1.00 1.04 1.13 1.04 .96 Ap1m2 KLA  ATP  ATP+KLA NM_009678 adaptor protein complex AP-1, mu 2 subunit (Ap1m2), transcript variant 2, mRNA [NM_009678] KLA .98 .99 1.04 1.09 1.02 1.03 1.05 ATP .95 .92 .99 1.03 .97 1.08 1.06 KLA/ATP 1.02 .99 .98 1.13 1.00 1.05 1.09 Ap1s1 KLA  ATP  ATP+KLA NM_007457 adaptor protein complex AP-1, sigma 1 (Ap1s1), mRNA [NM_007457] KLA 1.23 1.17 1.09 1.27 1.13 1.21 1.11 ATP .97 .90 1.09 .90 .86 .70 1.12 KLA/ATP 1.06 1.11 1.29 1.01 1.06 1.00 1.12 Ap1s2 KLA  ATP  ATP+KLA AK167690 14 days embryo liver cDNA, RIKEN full-length enriched library, clone:I530028J21 product:adaptor-related protein complex 1, sigma 2 subunit, full insert sequence. [AK167690] KLA .68 .58 .63 .51 .43 .24 .26 ATP 1.15 1.03 1.18 1.07 1.08 .60 .40 KLA/ATP .65 .66 .77 .68 .56 .39 .28 Ap1s2 KLA  ATP  ATP+KLA NM_026887 adaptor-related protein complex 1, sigma 2 subunit (Ap1s2), mRNA [NM_026887] KLA .81 .78 .72 .67 .50 .37 .53 ATP 1.12 1.14 1.21 1.37 1.09 .48 .59 KLA/ATP .89 .85 .95 .92 .63 .43 .48 Ap1s3 KLA  ATP  ATP+KLA ENSMUST00000067229 ens|AP-1 complex subunit sigma-3 (Adapter-related protein complex 1 sigma- 1C subunit) (Sigma1C-adaptin) (Sigma-adaptin 1C) (Adaptor protein complex AP-1 sigma-1C subunit) (Golgi adaptor HA1/AP1 adaptin sigma-1C subunit) (Clathrin assembly protein complex KLA 1.13 1.05 1.08 1.09 1.05 .84 .54 ATP .99 1.13 1.19 1.39 1.85 1.36 1.07 KLA/ATP 1.11 1.23 1.14 1.31 1.68 1.64 1.14 Ap1s3 KLA  ATP  ATP+KLA NM_183027 adaptor-related protein complex AP-1, sigma 3 (Ap1s3), mRNA [NM_183027] KLA .88 .96 1.03 1.09 1.00 .93 .97 ATP 1.01 1.06 1.29 1.29 1.79 1.48 1.29 KLA/ATP 1.03 1.07 1.13 1.15 1.41 1.51 1.28 Ap3b1 KLA  ATP  ATP+KLA NM_009680 adaptor-related protein complex 3, beta 1 subunit (Ap3b1), mRNA [NM_009680] KLA 1.76 1.77 1.93 2.08 1.73 1.55 1.20 ATP .92 .83 1.10 .87 .88 1.23 1.22 KLA/ATP 1.48 1.66 2.22 1.60 1.65 1.28 1.45 Ap3b2 KLA  ATP  ATP+KLA BC024722 adaptor-related protein complex 3, beta 2 subunit, mRNA (cDNA clone IMAGE:5364848), complete cds. [BC024722] KLA 1.07 1.04 .98 1.00 .97 1.03 1.01 ATP 1.02 1.01 1.08 1.07 1.01 1.03 1.10 KLA/ATP 1.01 1.00 1.00 .97 1.03 .98 1.06 Ap3b2 KLA  ATP  ATP+KLA NM_021492 adaptor-related protein complex 3, beta 2 subunit (Ap3b2), mRNA [NM_021492] KLA 1.04 .96 .95 1.02 1.03 .94 .91 ATP .99 .98 .97 .90 .98 1.04 .96 KLA/ATP .97 .94 .98 .95 .91 .95 .99 Ap3d1 KLA  ATP  ATP+KLA NM_007460 adaptor-related protein complex 3, delta 1 subunit (Ap3d1), mRNA [NM_007460] KLA .76 .78 .85 .78 1.03 1.17 1.08 ATP 1.00 .99 .76 .84 .75 .70 1.35 KLA/ATP .82 .82 .62 .59 .69 .74 1.17 Ap3m1 KLA  ATP  ATP+KLA BC010667 adaptor-related protein complex 3, mu 1 subunit, mRNA (cDNA clone IMAGE:3594657), partial cds [BC010667] KLA .86 .86 .87 .94 .86 .90 .79 ATP .87 .87 1.15 .77 .66 .58 .61 KLA/ATP .81 .78 1.00 .67 .72 .47 .40 Ap3m1 KLA  ATP  ATP+KLA NM_018829 adaptor-related protein complex 3, mu 1 subunit (Ap3m1), mRNA [NM_018829] KLA 1.09 1.13 1.27 1.08 1.23 1.25 1.23 ATP 1.01 1.06 1.01 .91 .67 .77 1.03 KLA/ATP 1.14 1.23 .98 .98 .73 .71 1.07 Ap3m2 KLA  ATP  ATP+KLA NM_029505 adaptor-related protein complex 3, mu 2 subunit (Ap3m2), transcript variant 2, mRNA [NM_029505] KLA 2.38 2.46 2.81 3.42 3.69 4.04 1.74 ATP 1.04 1.04 1.06 1.06 .74 1.47 1.92 KLA/ATP 2.42 2.46 2.77 2.76 2.04 3.07 4.68 Ap3s1 KLA  ATP  ATP+KLA NM_009681 adaptor-related protein complex 3, sigma 1 subunit (Ap3s1), mRNA [NM_009681] KLA 1.17 1.15 1.29 1.10 1.19 1.19 1.45 ATP 1.01 1.10 1.40 1.23 1.43 1.98 1.47 KLA/ATP 1.08 1.14 1.27 1.27 1.41 1.85 1.97 Ap3s2 KLA  ATP  ATP+KLA NM_009682 adaptor-related protein complex 3, sigma 2 subunit (Ap3s2), mRNA [NM_009682] KLA .87 .92 .94 .87 .95 1.01 1.07 ATP 1.01 1.13 .77 .80 .68 .75 .79 KLA/ATP .98 .98 .78 .82 .77 .72 .80 Ap4b1 KLA  ATP  ATP+KLA AF155157 adaptor-related protein complex AP-4 beta4 subunit mRNA, complete cds. [AF155157] KLA .92 .96 1.07 .96 1.01 1.14 1.38 ATP 1.00 1.00 .78 .86 1.44 1.72 1.38 KLA/ATP .98 .90 .79 .70 .77 1.25 1.83 Ap4b1 KLA  ATP  ATP+KLA NM_026193 adaptor-related protein complex AP-4, beta 1 (Ap4b1), mRNA [NM_026193] KLA .89 .88 .88 .90 .91 1.15 1.24 ATP .90 .84 .78 .74 1.34 1.97 1.36 KLA/ATP .82 .79 .75 .62 .73 1.30 1.91 Ap4e1 KLA  ATP  ATP+KLA NM_175550 adaptor-related protein complex AP-4, epsilon 1 (Ap4e1), mRNA [NM_175550] KLA 1.38 1.29 1.20 1.10 1.01 .96 1.08 ATP 1.07 1.07 1.09 .92 .83 .97 .94 KLA/ATP 1.31 1.39 1.24 1.01 .86 .84 .97 Ap4m1 KLA  ATP  ATP+KLA NM_021392 adaptor-related protein complex AP-4, mu 1 (Ap4m1), mRNA [NM_021392] KLA .53 .54 .56 .61 .78 .80 .74 ATP 1.13 1.11 1.05 .94 .59 .87 1.08 KLA/ATP .55 .55 .58 .57 .46 .71 .99 Ap4s1 KLA  ATP  ATP+KLA NM_021710 adaptor-related protein complex AP-4, sigma 1 (Ap4s1), mRNA [NM_021710] KLA .94 .93 .90 1.06 .95 1.17 .98 ATP .90 .80 1.24 .91 .89 .59 .76 KLA/ATP .86 .83 1.19 .85 .87 .59 .63 Arsa KLA  ATP  ATP+KLA NM_009713 arylsulfatase A (Arsa), mRNA [NM_009713] KLA .77 .77 .76 .71 .73 .69 .79 ATP .96 .98 .94 .80 .66 .53 .92 KLA/ATP .74 .79 .71 .62 .52 .43 .59 Arsb KLA  ATP  ATP+KLA AK083309 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:C920003D12 product:arylsulfatase B structural, full insert sequence. [AK083309] KLA .99 .88 .99 .93 .92 .98 1.00 ATP 1.07 1.12 1.10 .95 1.01 .97 .90 KLA/ATP .96 1.03 .95 .94 .94 .94 .99 Arsb KLA  ATP  ATP+KLA NM_009712 arylsulfatase B (Arsb), mRNA [NM_009712] KLA 1.11 1.13 1.16 1.02 .93 .79 .60 ATP 1.04 1.21 1.12 1.46 1.00 .74 .56 KLA/ATP 1.20 1.32 1.05 1.33 .84 .72 .54 Arsg KLA  ATP  ATP+KLA NM_028710 arylsulfatase G (Arsg), mRNA [NM_028710] KLA .83 .88 .82 .81 .77 .88 .75 ATP 1.00 1.01 .86 .82 1.87 1.12 .66 KLA/ATP .83 .79 .72 .71 .75 .71 .66 Asah1 KLA  ATP  ATP+KLA NM_019734 N-acylsphingosine amidohydrolase 1 (Asah1), mRNA [NM_019734] KLA .80 .84 .84 .69 .72 .78 1.09 ATP 1.04 1.26 1.00 1.15 .82 .53 .72 KLA/ATP .87 .89 .63 .82 .51 .47 .49 Atp6ap1 KLA  ATP  ATP+KLA NM_018794 ATPase, H+ transporting, lysosomal accessory protein 1 (Atp6ap1), mRNA [NM_018794] KLA .73 .83 .89 .71 .74 .71 1.06 ATP 1.05 1.08 .94 1.12 .99 .79 1.07 KLA/ATP .90 .81 .72 .84 .62 .64 .97 Atp6v0a1 KLA  ATP  ATP+KLA AK045877 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230316H04 product:unclassifiable, full insert sequence [AK045877] KLA .65 .64 .58 .48 .57 .46 .29 ATP .64 .28 .48 .28 .45 .30 .91 KLA/ATP .51 .26 .37 .31 .54 .45 .63 Atp6v0a1 KLA  ATP  ATP+KLA NM_016920 ATPase, H+ transporting, lysosomal V0 subunit A1 (Atp6v0a1), mRNA [NM_016920] KLA .88 .91 .88 .80 .66 .52 .45 ATP 1.05 1.22 .91 1.05 .58 .40 1.46 KLA/ATP .97 1.04 .80 .89 .55 .43 .75 Atp6v0a2 KLA  ATP  ATP+KLA AK160318 16 days embryo lung cDNA, RIKEN full-length enriched library, clone:8430408C20 product:unclassifiable, full insert sequence [AK160318] KLA 1.21 1.13 1.18 1.30 1.39 1.58 1.38 ATP 1.10 .94 .55 .35 .72 .96 .84 KLA/ATP 1.12 1.08 .82 .54 .81 1.05 .59 Atp6v0a2 KLA  ATP  ATP+KLA BC112905 ATPase, H+ transporting, lysosomal V0 subunit A2, mRNA (cDNA clone MGC:118073 IMAGE:3670722), complete cds [BC112905] KLA 1.65 1.66 1.74 2.07 1.97 2.78 2.71 ATP .88 .61 .53 .30 .38 1.26 2.12 KLA/ATP 1.38 1.29 .91 .62 .59 1.36 2.13 Atp6v0a2 KLA  ATP  ATP+KLA NM_011596 ATPase, H+ transporting, lysosomal V0 subunit A2 (Atp6v0a2), mRNA [NM_011596] KLA 2.26 2.07 2.01 2.71 2.48 3.69 2.76 ATP .79 .64 .62 .42 .62 2.31 3.11 KLA/ATP 1.69 1.57 1.47 .90 1.06 2.56 4.84 Atp6v0a4 KLA  ATP  ATP+KLA NM_080467 ATPase, H+ transporting, lysosomal V0 subunit A4 (Atp6v0a4), mRNA [NM_080467] KLA 1.01 1.00 .99 1.03 1.01 1.02 .98 ATP 1.02 1.05 .93 1.03 1.05 1.01 .97 KLA/ATP 1.02 .94 1.00 .99 1.00 1.01 1.03 Atp6v0b KLA  ATP  ATP+KLA NM_033617 ATPase, H+ transporting, lysosomal V0 subunit B (Atp6v0b), mRNA [NM_033617] KLA .91 1.00 1.07 .81 1.25 1.34 1.44 ATP 1.12 1.33 .80 1.41 1.47 1.67 1.77 KLA/ATP 1.20 1.16 .62 1.28 1.01 1.77 2.37 Atp6v0c KLA  ATP  ATP+KLA NM_009729 ATPase, H+ transporting, lysosomal V0 subunit C (Atp6v0c), mRNA [NM_009729] KLA .89 .98 1.05 .90 1.18 1.38 1.52 ATP 1.07 1.28 .93 1.66 1.48 1.35 2.35 KLA/ATP 1.10 1.12 .67 1.50 1.18 1.66 2.51 Atp6v0d1 KLA  ATP  ATP+KLA NM_013477 ATPase, H+ transporting, lysosomal V0 subunit D1 (Atp6v0d1), mRNA [NM_013477] KLA .84 .85 .94 .79 1.10 1.24 1.27 ATP 1.18 1.48 .94 1.40 1.12 .75 1.85 KLA/ATP 1.05 1.06 .59 1.06 .83 .85 1.96 Atp6v0d2 KLA  ATP  ATP+KLA NM_175406 ATPase, H+ transporting, lysosomal V0 subunit D2 (Atp6v0d2), mRNA [NM_175406] KLA .77 .72 .64 .54 .43 .27 .18 ATP 1.19 1.35 1.06 1.47 1.46 .79 .96 KLA/ATP .78 .95 .63 1.12 1.21 1.01 .50 Atp6v1h KLA  ATP  ATP+KLA AK081492 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130021C16 product:hypothetical V-ATPase subunit H containing protein, full insert sequence. [AK081492] KLA 1.09 .98 .77 .93 1.08 1.00 1.10 ATP 1.16 1.43 2.03 3.91 3.02 1.23 1.46 KLA/ATP 1.02 .98 1.06 2.30 2.07 1.28 1.06 Atp6v1h KLA  ATP  ATP+KLA NM_133826 ATPase, H+ transporting, lysosomal V1 subunit H (Atp6v1h), mRNA [NM_133826] KLA 1.13 1.15 1.12 1.05 1.05 .96 1.20 ATP 1.04 1.04 .86 1.06 2.07 2.38 1.90 KLA/ATP 1.14 1.17 .98 1.09 1.55 2.06 1.29 Cd164 KLA  ATP  ATP+KLA AK018009 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830453P09 product:CD164 antigen, full insert sequence. [AK018009] KLA 1.01 .99 .98 .95 .98 .98 .82 ATP .95 1.05 .94 1.01 1.00 1.08 1.12 KLA/ATP .94 .95 1.06 .94 .97 .99 1.01 Cd164 KLA  ATP  ATP+KLA NM_016898 CD164 antigen (Cd164), mRNA [NM_016898] KLA 3.04 3.30 4.10 3.96 4.05 3.72 1.24 ATP 1.01 1.01 1.18 1.28 1.58 3.68 3.68 KLA/ATP 3.03 3.38 3.60 4.43 3.76 6.03 5.67 Cd63 KLA  ATP  ATP+KLA NM_001042580 Cd63 antigen (Cd63), transcript variant 1, mRNA [NM_001042580] KLA .98 .93 .83 .90 .79 .84 .87 ATP .92 .97 .95 .93 1.09 1.30 1.52 KLA/ATP .84 .94 .98 .84 1.20 1.23 1.27 Cd68 KLA  ATP  ATP+KLA NM_009853 CD68 antigen (Cd68), mRNA [NM_009853] KLA .76 .78 .81 .77 .81 .72 .80 ATP 1.11 1.19 .79 1.21 1.15 .95 1.36 KLA/ATP .90 .93 .64 .98 .81 .93 1.29 Cln3 KLA  ATP  ATP+KLA BC047120 ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease), mRNA (cDNA clone MGC:5851 IMAGE:3501036), complete cds. [BC047120] KLA 2.36 1.95 1.84 1.39 1.35 .89 .96 ATP 1.39 1.16 .73 1.08 1.26 1.48 .98 KLA/ATP 3.16 3.13 1.89 .80 1.19 1.60 1.49 Cln3 KLA  ATP  ATP+KLA NM_009907 ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) (Cln3), mRNA [NM_009907] KLA 1.72 1.78 1.60 1.26 1.38 1.19 1.44 ATP 1.03 1.08 .79 1.02 1.07 1.24 1.56 KLA/ATP 2.06 2.13 1.64 1.93 1.18 1.46 3.02 Cln5 KLA  ATP  ATP+KLA NM_001033242 ceroid-lipofuscinosis, neuronal 5 (Cln5), mRNA [NM_001033242] KLA 3.01 3.15 3.03 2.50 2.38 1.98 2.27 ATP .98 1.02 .96 1.30 3.32 4.15 2.65 KLA/ATP 3.33 3.33 2.82 2.73 3.15 2.72 2.20 Clta KLA  ATP  ATP+KLA AK035903 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630016K07 product:unclassifiable, full insert sequence [AK035903] KLA 1.01 1.00 .97 1.02 1.01 1.12 1.09 ATP 1.04 .98 .91 1.05 1.02 1.01 .95 KLA/ATP 1.00 .99 .93 1.07 1.09 .98 .99 Clta KLA  ATP  ATP+KLA NM_016760 clathrin, light polypeptide (Lca) (Clta), transcript variant 3, mRNA [NM_016760] KLA .68 .70 .75 .68 .70 .77 .55 ATP 1.06 1.05 .93 .97 .81 .60 .75 KLA/ATP .75 .76 .68 .71 .69 .64 .42 Cltb KLA  ATP  ATP+KLA NM_028870 clathrin, light polypeptide (Lcb) (Cltb), mRNA [NM_028870] KLA .91 1.01 .97 .78 .71 .52 .73 ATP 1.15 1.32 1.07 1.72 1.96 1.94 1.31 KLA/ATP 1.07 1.17 .76 1.17 1.18 2.12 1.06 Cltc KLA  ATP  ATP+KLA AK039453 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330045B10 product:CLATHRIN HEAVY CHAIN 1 (CLH-17) homolog [Homo sapiens], full insert sequence. [AK039453] KLA 1.07 1.00 1.01 1.00 1.03 1.06 1.02 ATP 1.00 .99 1.02 .97 1.00 1.02 1.00 KLA/ATP 1.01 1.01 1.02 .98 1.04 .98 .99 Cltc KLA  ATP  ATP+KLA NM_001003908 clathrin, heavy polypeptide (Hc) (Cltc), mRNA [NM_001003908] KLA .94 1.00 .98 .89 1.18 1.02 .93 ATP 1.21 1.42 .72 .89 .93 .96 .75 KLA/ATP 1.12 1.21 .48 .72 .57 .87 .81 Ctns KLA  ATP  ATP+KLA NM_031251 cystinosis, nephropathic (Ctns), mRNA [NM_031251] KLA .34 .33 .31 .35 .37 .56 .66 ATP .97 .94 1.16 1.21 1.67 1.56 1.46 KLA/ATP .32 .31 .36 .32 .81 1.32 1.22 Ctsa KLA  ATP  ATP+KLA NM_008906 cathepsin A (Ctsa), transcript variant 1, mRNA [NM_008906] KLA .83 .81 .76 .72 .74 .66 .70 ATP 1.03 1.06 .93 1.05 .90 .73 1.00 KLA/ATP .83 .86 .74 .91 .76 .62 .73 Ctsb KLA  ATP  ATP+KLA NM_007798 cathepsin B (Ctsb), mRNA [NM_007798] KLA .89 .86 .82 .80 .84 .84 .95 ATP .98 1.04 .91 .83 .85 .82 1.00 KLA/ATP .80 .87 .81 .81 .68 .68 .85 Ctsc KLA  ATP  ATP+KLA NM_009982 cathepsin C (Ctsc), mRNA [NM_009982] KLA 3.58 3.79 5.01 5.07 6.47 6.78 3.88 ATP 1.02 1.30 1.35 1.59 1.30 1.42 .66 KLA/ATP 3.49 4.21 4.60 5.92 4.15 4.37 2.72 Ctsd KLA  ATP  ATP+KLA NM_009983 cathepsin D (Ctsd), mRNA [NM_009983] KLA .67 .69 .72 .56 .62 .52 .79 ATP 1.07 1.19 .71 .88 .77 .60 1.14 KLA/ATP .86 .84 .49 .67 .49 .51 .82 Ctse KLA  ATP  ATP+KLA BC005432 cathepsin E, mRNA (cDNA clone MGC:5924 IMAGE:3601519), complete cds. [BC005432] KLA 1.17 1.24 1.23 1.28 1.09 1.08 .96 ATP 1.03 .99 1.02 .97 .93 .94 .91 KLA/ATP 1.15 1.15 1.42 1.14 1.15 1.17 1.03 Ctsf KLA  ATP  ATP+KLA NM_019861 cathepsin F (Ctsf), mRNA [NM_019861] KLA .93 .96 .96 .94 .83 .75 .42 ATP .99 1.07 1.03 1.28 1.00 .69 .47 KLA/ATP 1.05 1.06 .97 1.37 .82 .64 .47 Ctsg KLA  ATP  ATP+KLA NM_007800 cathepsin G (Ctsg), mRNA [NM_007800] KLA 1.15 1.23 1.36 1.24 1.14 1.09 1.22 ATP .97 1.04 1.19 1.22 1.30 1.19 .98 KLA/ATP 1.19 1.30 1.52 1.58 1.34 1.23 1.07 Ctsh KLA  ATP  ATP+KLA NM_007801 cathepsin H (Ctsh), mRNA [NM_007801] KLA 1.54 1.44 1.60 1.63 1.67 2.20 3.15 ATP .95 .88 1.13 .95 .98 1.15 2.58 KLA/ATP 1.39 1.44 1.86 1.44 1.68 2.48 6.41 Ctsj KLA  ATP  ATP+KLA NM_012007 cathepsin J (Ctsj), mRNA [NM_012007] KLA 1.00 1.08 .97 1.04 1.00 1.03 .97 ATP 1.03 1.00 .97 1.00 .98 1.03 1.12 KLA/ATP 1.03 .99 1.07 1.02 1.01 .98 1.03 Ctsk KLA  ATP  ATP+KLA NM_007802 cathepsin K (Ctsk), mRNA [NM_007802] KLA 1.02 1.14 1.16 1.37 1.40 1.95 2.05 ATP 1.04 1.06 1.34 2.32 3.59 8.92 14.36 KLA/ATP 1.08 1.23 1.62 2.29 4.63 15.04 24.14 Ctsl KLA  ATP  ATP+KLA NM_009984 cathepsin L (Ctsl), mRNA [NM_009984] KLA .85 .79 .72 .80 .79 .84 .75 ATP 1.02 1.01 1.16 .87 1.73 3.14 6.44 KLA/ATP .72 .80 1.12 .89 1.20 2.53 3.79 Ctsm KLA  ATP  ATP+KLA NM_022326 cathepsin M (Ctsm), mRNA [NM_022326] KLA 1.03 .99 .99 .97 1.00 .98 .87 ATP 1.05 1.00 1.03 .99 1.01 .96 .91 KLA/ATP 1.06 1.06 1.04 1.01 .91 .96 .86 Ctso KLA  ATP  ATP+KLA NM_177662 cathepsin O (Ctso), mRNA [NM_177662] KLA 1.02 1.02 1.12 .97 1.00 1.16 1.36 ATP .94 .95 1.32 1.04 .86 .67 1.06 KLA/ATP .99 .99 1.23 .97 .77 .71 1.01 Ctss KLA  ATP  ATP+KLA NM_021281 cathepsin S (Ctss), mRNA [NM_021281] KLA 1.10 1.10 1.12 1.19 1.11 1.43 2.02 ATP .98 .91 1.04 .79 .87 1.01 1.82 KLA/ATP 1.05 .97 1.18 .98 1.12 1.24 2.03 Ctsw KLA  ATP  ATP+KLA NM_009985 cathepsin W (Ctsw), mRNA [NM_009985] KLA 1.00 .96 .97 .95 .97 .97 1.02 ATP 1.02 .97 1.09 1.09 .99 1.00 .93 KLA/ATP .97 .98 .93 .98 .97 .95 .98 Ctsz KLA  ATP  ATP+KLA NM_022325 cathepsin Z (Ctsz), mRNA [NM_022325] KLA 1.08 1.18 1.21 1.21 1.57 1.97 3.44 ATP .99 1.02 .82 1.09 1.34 1.71 2.86 KLA/ATP 1.16 1.20 1.02 1.27 1.40 1.76 3.09 Dnase2a KLA  ATP  ATP+KLA AK018651 adult male cecum cDNA, RIKEN full-length enriched library, clone:9130026D18 product:syntrophin associated serine/threonine kinase, full insert sequence. [AK018651] KLA .77 .74 .77 .77 .82 .92 .95 ATP .96 .95 2.59 3.13 4.24 2.12 1.03 KLA/ATP .86 .76 1.06 1.57 4.39 2.19 1.68 Dnase2b KLA  ATP  ATP+KLA NM_019957 deoxyribonuclease II beta (Dnase2b), mRNA [NM_019957] KLA 1.00 .97 1.05 .97 .97 1.00 1.00 ATP 1.02 .96 1.08 1.04 .98 .99 .99 KLA/ATP .99 1.02 1.04 .95 1.00 1.02 1.06 Entpd4 KLA  ATP  ATP+KLA NM_026174 ectonucleoside triphosphate diphosphohydrolase 4 (Entpd4), mRNA [NM_026174] KLA .89 .83 .82 .74 .67 .78 .92 ATP .97 1.05 .92 .87 .71 .69 .92 KLA/ATP .86 .83 .73 .73 .61 .73 .78 Fuca1 KLA  ATP  ATP+KLA NM_024243 fucosidase, alpha-L- 1, tissue (Fuca1), mRNA [NM_024243] KLA .72 .75 .70 .66 .61 .56 .59 ATP .97 1.06 .90 1.25 .93 .67 .99 KLA/ATP .77 .78 .65 .94 .66 .61 .92 Gaa KLA  ATP  ATP+KLA NM_008064 glucosidase, alpha, acid (Gaa), mRNA [NM_008064] KLA .85 .84 .84 .78 .83 .87 1.18 ATP .97 .96 .75 .78 .74 .72 1.01 KLA/ATP .88 .91 .78 .78 .71 .71 .86 Galc KLA  ATP  ATP+KLA NM_008079 galactosylceramidase (Galc), mRNA [NM_008079] KLA .70 .68 .66 .54 .40 .42 .62 ATP 1.11 1.33 1.00 1.23 .90 .72 .61 KLA/ATP .80 .80 .56 .71 .46 .53 .48 Galns KLA  ATP  ATP+KLA NM_016722 galactosamine (N-acetyl)-6-sulfate sulfatase (Galns), mRNA [NM_016722] KLA .99 1.00 1.06 1.00 1.07 1.14 1.41 ATP 1.18 1.19 .97 1.33 1.03 .80 1.15 KLA/ATP 1.11 1.12 .96 1.38 .85 .83 1.55 Gba KLA  ATP  ATP+KLA NM_001077411 glucosidase, beta, acid (Gba), mRNA [NM_001077411] KLA .86 .89 .92 .84 .95 1.11 1.65 ATP .97 .99 .60 .74 .63 .76 2.19 KLA/ATP .95 .85 .52 .74 .50 .81 2.57 Gga1 KLA  ATP  ATP+KLA NM_145929 golgi associated, gamma adaptin ear containing, ARF binding protein 1 (Gga1), mRNA [NM_145929] KLA 1.16 1.20 1.35 1.30 1.38 1.27 1.36 ATP 1.08 1.21 .99 1.40 .93 .92 1.18 KLA/ATP 1.28 1.24 1.01 1.48 .99 1.03 1.51 Gga2 KLA  ATP  ATP+KLA AK051911 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230018D20 product:unclassifiable, full insert sequence. [AK051911] KLA 1.01 .95 .99 .98 .98 .97 .91 ATP .99 1.06 1.03 .94 1.02 .98 1.00 KLA/ATP 1.01 1.10 .99 .99 .98 .89 .98 Gga2 KLA  ATP  ATP+KLA NM_028758 golgi associated, gamma adaptin ear containing, ARF binding protein 2 (Gga2), mRNA [NM_028758] KLA .51 .54 .48 .44 .30 .28 .69 ATP 1.10 1.15 .87 1.01 2.07 1.89 1.27 KLA/ATP .64 .59 .51 .52 .70 1.04 .54 Gga3 KLA  ATP  ATP+KLA NM_173048 golgi associated, gamma adaptin ear containing, ARF binding protein 3 (Gga3), mRNA [NM_173048] KLA .83 .80 .91 .96 1.05 1.05 1.21 ATP 1.08 1.02 .96 .78 1.03 1.05 1.34 KLA/ATP .93 .88 .85 .69 .95 .94 1.47 Gla KLA  ATP  ATP+KLA NM_013463 galactosidase, alpha (Gla), mRNA [NM_013463] KLA .91 .95 1.02 .93 1.02 1.35 1.99 ATP 1.06 1.22 1.08 1.49 1.31 1.44 3.32 KLA/ATP 1.01 1.05 .89 1.54 1.26 1.98 5.13 Gla KLA  ATP  ATP+KLA U34071 alpha-galactosidase A mRNA, complete cds. [U34071] KLA .99 .99 1.18 1.28 1.30 1.59 1.66 ATP 1.12 1.20 1.32 1.74 1.93 1.44 1.50 KLA/ATP 1.12 1.24 1.28 1.98 2.55 2.85 2.82 Glb1 KLA  ATP  ATP+KLA NM_009752 galactosidase, beta 1 (Glb1), mRNA [NM_009752] KLA .93 .96 1.02 .85 .86 .81 .80 ATP 1.03 1.10 1.01 1.13 .97 .82 .75 KLA/ATP 1.08 1.04 .86 1.06 .81 .81 .66 Gm2a KLA  ATP  ATP+KLA NM_010299 GM2 ganglioside activator protein (Gm2a), mRNA [NM_010299] KLA 1.05 1.10 1.13 .99 .91 .83 .82 ATP 1.15 1.24 1.21 1.58 1.16 .95 .76 KLA/ATP 1.25 1.19 1.13 1.34 .92 .84 .85 Gnptab KLA  ATP  ATP+KLA NM_001004164 N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits (Gnptab), mRNA [NM_001004164] KLA 1.30 1.36 1.46 1.33 1.38 1.15 1.09 ATP 1.02 1.19 1.21 1.17 1.30 1.15 2.26 KLA/ATP 1.34 1.46 1.36 1.38 1.28 1.64 1.71 Gnptg KLA  ATP  ATP+KLA AK078230 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430527N14 product:hypothetical Extracytoplasmic domain of cation-dependent mannose 6-phosphate receptor structure containing protein, full insert sequence [AK0782 KLA .98 .86 1.00 .89 .96 .88 .91 ATP 1.05 .97 .95 .99 .99 .83 .82 KLA/ATP .98 .99 .88 .95 .89 .91 .80 Gnptg KLA  ATP  ATP+KLA NM_172529 N-acetylglucosamine-1-phosphotransferase, gamma subunit (Gnptg), mRNA [NM_172529] KLA .98 .96 1.06 .99 .98 .86 .98 ATP 1.15 1.06 1.14 1.38 1.29 .97 1.33 KLA/ATP 1.05 1.13 1.10 1.15 1.09 .86 1.07 Gns KLA  ATP  ATP+KLA AK040524 0 day neonate thymus cDNA, RIKEN full-length enriched library, clone:A430105C13 product:glucosamine (N-acetyl)-6-sulfatase, full insert sequence. [AK040524] KLA 2.06 2.05 1.93 2.03 2.37 1.56 1.22 ATP 1.18 1.15 .98 2.24 1.28 1.03 1.52 KLA/ATP 2.15 2.20 1.53 2.63 1.61 1.42 1.54 Gns KLA  ATP  ATP+KLA NM_029364 glucosamine (N-acetyl)-6-sulfatase (Gns), mRNA [NM_029364] KLA 1.48 1.47 1.80 1.48 1.81 2.03 1.87 ATP 1.09 1.27 .92 1.16 .95 .85 1.54 KLA/ATP 1.57 1.62 1.22 1.69 .98 1.34 1.93 Gusb KLA  ATP  ATP+KLA NM_010368 glucuronidase, beta (Gusb), mRNA [NM_010368] KLA .65 .67 .62 .52 .52 .47 .52 ATP 1.07 1.11 .95 1.00 .80 .57 .58 KLA/ATP .72 .71 .56 .62 .52 .48 .38 Hexa KLA  ATP  ATP+KLA NM_010421 hexosaminidase A (Hexa), mRNA [NM_010421] KLA .74 .76 .70 .63 .57 .52 .51 ATP .98 1.04 .82 .81 .68 .52 .64 KLA/ATP .76 .78 .63 .60 .48 .37 .31 Hexb KLA  ATP  ATP+KLA NM_010422 hexosaminidase B (Hexb), mRNA [NM_010422] KLA .82 .90 .81 .70 .64 .64 .71 ATP .95 1.03 1.11 .83 .72 .58 .63 KLA/ATP .80 .83 .77 .68 .53 .45 .50 Hgsnat KLA  ATP  ATP+KLA NM_029884 heparan-alpha-glucosaminide N-acetyltransferase (Hgsnat), mRNA [NM_029884] KLA .73 .74 .73 .76 .70 1.27 1.85 ATP .91 .98 1.13 1.21 1.13 1.59 2.63 KLA/ATP .69 .68 .78 .98 1.06 2.45 4.56 Hyal1 KLA  ATP  ATP+KLA NM_008317 hyaluronoglucosaminidase 1 (Hyal1), mRNA [NM_008317] KLA .31 .28 .26 .26 .29 .53 .76 ATP 1.03 1.03 .71 1.21 1.31 .46 3.39 KLA/ATP .31 .32 .33 .53 .84 .58 2.71 Ids KLA  ATP  ATP+KLA NM_010498 iduronate 2-sulfatase (Ids), transcript variant 1, mRNA [NM_010498] KLA 1.25 1.29 1.33 1.30 1.22 1.23 1.13 ATP 1.02 1.11 1.09 1.09 .81 .64 .83 KLA/ATP 1.24 1.22 1.13 1.13 .78 .77 .86 Idua KLA  ATP  ATP+KLA NM_008325 iduronidase, alpha-L- (Idua), mRNA [NM_008325] KLA .88 .91 1.00 .87 .91 1.00 1.22 ATP .97 1.03 .99 1.04 .89 .64 .85 KLA/ATP .93 .97 1.01 .97 .72 .63 .86 Igf2r KLA  ATP  ATP+KLA NM_010515 insulin-like growth factor 2 receptor (Igf2r), mRNA [NM_010515] KLA .88 .84 .75 .59 .65 .70 .72 ATP .98 1.04 1.20 1.03 1.21 .77 1.03 KLA/ATP .85 .86 .94 .59 .60 .39 .75 Lamp1 KLA  ATP  ATP+KLA NM_010684 lysosomal-associated membrane protein 1 (Lamp1), mRNA [NM_010684] KLA .88 .89 .92 .83 .83 .86 1.10 ATP .98 1.02 .91 .87 .92 .94 1.31 KLA/ATP .88 .91 .81 .80 .78 .83 1.21 Lamp2 KLA  ATP  ATP+KLA NM_001017959 lysosomal-associated membrane protein 2 (Lamp2), transcript variant 1, mRNA [NM_001017959] KLA 1.14 1.12 1.25 1.30 1.21 1.30 1.12 ATP .98 .91 1.17 1.00 .91 1.00 .83 KLA/ATP 1.08 1.05 1.33 1.13 1.17 1.45 1.29 Lamp2 KLA  ATP  ATP+KLA NM_010685 lysosomal-associated membrane protein 2 (Lamp2), transcript variant 2, mRNA [NM_010685] KLA 1.28 1.27 1.42 1.54 1.36 1.50 1.14 ATP 1.03 .95 1.18 .77 .86 .80 .71 KLA/ATP 1.27 1.23 1.50 .91 1.00 .95 1.21 Lamp3 KLA  ATP  ATP+KLA AK086898 0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030010B20 product:unclassifiable, full insert sequence. [AK086898] KLA 1.00 1.04 .97 1.04 1.06 1.02 1.08 ATP .96 .99 1.02 1.00 1.03 1.04 1.00 KLA/ATP 1.01 .94 .98 1.07 1.05 1.01 .99 Lamp3 KLA  ATP  ATP+KLA NM_177356 lysosomal-associated membrane protein 3 (Lamp3), mRNA [NM_177356] KLA 1.00 .99 .97 .92 .91 .89 .95 ATP 1.05 1.02 1.05 1.21 1.41 1.20 .89 KLA/ATP 1.04 1.01 1.05 1.08 1.27 1.11 .81 Laptm4a KLA  ATP  ATP+KLA NM_008640 lysosomal-associated protein transmembrane 4A (Laptm4a), mRNA [NM_008640] KLA 1.18 1.19 1.47 1.64 1.73 1.94 1.56 ATP 1.03 .98 1.09 1.00 1.14 1.21 1.00 KLA/ATP 1.23 1.29 1.58 1.29 1.56 1.96 1.59 Laptm4b KLA  ATP  ATP+KLA NM_033521 lysosomal-associated protein transmembrane 4B (Laptm4b), mRNA [NM_033521] KLA 1.04 1.11 1.11 1.03 .92 .77 .82 ATP .97 1.03 1.07 1.10 1.14 1.21 1.31 KLA/ATP 1.12 1.13 1.13 1.20 1.06 1.02 1.24 Laptm5 KLA  ATP  ATP+KLA NM_010686 lysosomal-associated protein transmembrane 5 (Laptm5), mRNA [NM_010686] KLA .80 .84 .78 .72 .73 .71 .64 ATP 1.01 1.19 .99 1.26 .99 .75 .85 KLA/ATP .85 .87 .79 1.01 .77 .72 .85 Lgmn KLA  ATP  ATP+KLA NM_011175 legumain (Lgmn), mRNA [NM_011175] KLA .76 .74 .86 .57 .93 1.19 1.60 ATP 1.01 1.01 .89 .82 .71 .55 1.31 KLA/ATP .78 .78 .63 .73 .67 .84 1.45 Lipa KLA  ATP  ATP+KLA AK083099 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630012O05 product:unclassifiable, full insert sequence. [AK083099] KLA .46 .38 .29 .31 .42 .55 .68 ATP .69 .39 .26 .79 1.80 1.07 .96 KLA/ATP .39 .32 .40 .86 1.05 .85 .85 Lipa KLA  ATP  ATP+KLA NM_021460 lysosomal acid lipase A (Lipa), transcript variant 1, mRNA [NM_021460] KLA .51 .50 .54 .36 .29 .32 .46 ATP .89 1.09 .86 .80 .83 1.00 .88 KLA/ATP .48 .57 .44 .49 .44 .67 .63 Lypla3 KLA  ATP  ATP+KLA NM_133792 lysophospholipase 3 (Lypla3), mRNA [NM_133792] KLA .39 .40 .37 .35 .43 .61 .79 ATP 1.16 1.25 1.07 1.55 2.07 1.18 .64 KLA/ATP .48 .44 .38 .71 1.44 1.29 .47 M6pr KLA  ATP  ATP+KLA NM_010749 mannose-6-phosphate receptor, cation dependent (M6pr), mRNA [NM_010749] KLA 1.70 1.73 1.86 1.55 2.23 2.42 1.82 ATP 1.08 1.25 1.03 .97 1.03 1.33 1.75 KLA/ATP 1.62 1.79 1.52 1.62 1.27 1.82 2.37 Man2b1 KLA  ATP  ATP+KLA AK054315 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330014I09 product:mannosidase 2, alpha B1, full insert sequence. [AK054315] KLA 1.00 .97 .91 .97 .93 .92 .94 ATP .98 .99 .89 1.01 .92 .94 .97 KLA/ATP .94 .95 .90 .93 1.00 .94 .96 Man2b1 KLA  ATP  ATP+KLA NM_010764 mannosidase 2, alpha B1 (Man2b1), mRNA [NM_010764] KLA .78 .76 .76 .67 .59 .51 .37 ATP .90 .94 .92 .84 .74 .54 .43 KLA/ATP .74 .77 .73 .64 .52 .37 .27 Manba KLA  ATP  ATP+KLA AK037629 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130030I04 product:unclassifiable, full insert sequence. [AK037629] KLA 1.01 .99 .98 1.09 1.04 1.02 1.01 ATP .97 1.00 .91 .99 .96 1.02 .99 KLA/ATP .97 1.03 .92 .96 1.04 .97 .93 Manba KLA  ATP  ATP+KLA NM_027288 mannosidase, beta A, lysosomal (Manba), mRNA [NM_027288] KLA .60 .62 .56 .49 .42 .55 .77 ATP .98 1.03 1.03 1.12 .93 .47 .75 KLA/ATP .63 .65 .58 .62 .51 .39 .76 Mcoln1 KLA  ATP  ATP+KLA AK008732 adult male stomach cDNA, RIKEN full-length enriched library, clone:2210015I05 product:unclassifiable, full insert sequence. [AK008732] KLA .51 .53 .63 .62 .70 .71 .87 ATP .96 1.03 .91 .89 1.01 .70 1.44 KLA/ATP .54 .54 .56 .52 .89 .79 1.15 Mcoln1 KLA  ATP  ATP+KLA NM_053177 mucolipin 1 (Mcoln1), mRNA [NM_053177] KLA .73 .70 .74 .75 .70 .75 1.01 ATP 1.01 .96 1.11 .97 .97 .63 1.29 KLA/ATP .70 .75 .87 .73 .90 .65 1.01 Mfsd8 KLA  ATP  ATP+KLA AK084485 13 days embryo heart cDNA, RIKEN full-length enriched library, clone:D330006D04 product:unclassifiable, full insert sequence [AK084485] KLA .94 1.02 .97 .91 .82 .97 1.04 ATP 1.05 .89 .75 1.03 .92 .83 .99 KLA/ATP 1.00 .97 .80 .86 .90 .96 .89 Mfsd8 KLA  ATP  ATP+KLA NM_028140 major facilitator superfamily domain containing 8 (Mfsd8), mRNA [NM_028140] KLA 1.17 1.33 1.35 1.24 1.22 1.15 1.38 ATP 1.05 1.13 .98 .91 .75 .78 1.14 KLA/ATP 1.25 1.30 1.07 1.11 .80 .91 1.15 Mm.27481 6 KLA  ATP  ATP+KLA 88853577 Unknown KLA .60 .50 .46 .47 .39 .43 .30 ATP .95 .83 1.08 .67 .48 .20 .79 KLA/ATP .43 .48 .60 .38 .30 .17 .19 Mm.29002 6 KLA  ATP  ATP+KLA 146141141 Unknown KLA .86 .76 .74 .94 .70 .57 .57 ATP 1.05 .94 1.16 1.33 2.13 2.57 1.15 KLA/ATP .74 .84 1.09 1.07 1.49 2.42 1.05 Mm.42016 7 KLA  ATP  ATP+KLA 87299638 Unknown KLA .70 .74 .78 .66 .62 .63 .89 ATP 1.16 1.13 1.03 1.37 1.31 .99 1.77 KLA/ATP .93 .79 .68 1.06 .83 .91 1.24 Mm.47242 0 KLA  ATP  ATP+KLA 118131153 Unknown KLA .76 .71 .67 .68 .52 .49 .29 ATP 1.00 .92 1.06 .93 1.34 1.26 .37 KLA/ATP .68 .66 .78 .79 1.61 1.54 .47 Mm.47565 8 KLA  ATP  ATP+KLA 145966880 Unknown KLA .20 .19 .15 .15 .17 .47 .71 ATP .85 .82 .70 1.24 1.23 .39 3.48 KLA/ATP .18 .20 .18 .38 .85 .56 2.73 Naga KLA  ATP  ATP+KLA NM_008669 N-acetyl galactosaminidase, alpha (Naga), mRNA [NM_008669] KLA 1.05 1.04 1.08 1.06 .99 .94 1.09 ATP 1.02 1.20 .96 1.63 1.00 .72 1.08 KLA/ATP 1.09 1.19 .88 1.54 .81 .77 1.20 Naglu KLA  ATP  ATP+KLA AK158045 adult inner ear cDNA, RIKEN full-length enriched library, clone:F930021C23 product:alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB), full insert sequence [AK158045] KLA 1.06 1.01 1.05 .98 1.02 1.04 1.01 ATP .99 1.05 .96 1.00 1.05 .93 1.03 KLA/ATP 1.03 .99 1.04 1.03 .96 .98 .91 Naglu KLA  ATP  ATP+KLA NM_013792 alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB) (Naglu), mRNA [NM_013792] KLA .67 .71 .71 .63 .59 .60 .87 ATP 1.02 1.07 1.00 1.14 .84 .57 .95 KLA/ATP .72 .72 .71 .84 .58 .54 .72 Nagpa KLA  ATP  ATP+KLA NM_013796 N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (Nagpa), mRNA [NM_013796] KLA 1.53 1.55 1.50 1.33 1.24 1.23 1.21 ATP 1.00 1.08 1.17 1.51 1.24 .90 1.04 KLA/ATP 1.53 1.81 2.11 2.34 1.63 1.22 1.11 Napsa KLA  ATP  ATP+KLA NM_008437 napsin A aspartic peptidase (Napsa), mRNA [NM_008437] KLA 1.63 1.83 1.75 1.66 1.40 1.19 .87 ATP .99 1.07 1.10 1.48 1.16 .95 1.02 KLA/ATP 1.76 1.85 1.78 2.36 1.60 1.35 1.48 Neu1 KLA  ATP  ATP+KLA NM_010893 neuraminidase 1 (Neu1), mRNA [NM_010893] KLA .59 .58 .57 .66 .88 1.30 1.59 ATP .98 1.01 1.08 1.31 1.76 2.01 2.47 KLA/ATP .57 .59 .70 .78 1.18 1.73 2.99 Npc1 KLA  ATP  ATP+KLA AK171371 B6-derived CD11 +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F730103J08 product:Niemann Pick type C1, full insert sequence [AK171371] KLA 1.00 1.00 .97 .93 .91 .98 1.01 ATP 1.01 .93 .98 1.02 1.05 .98 1.04 KLA/ATP .94 .98 .92 .99 1.03 .95 1.03 Npc1 KLA  ATP  ATP+KLA NM_008720 Niemann Pick type C1 (Npc1), mRNA [NM_008720] KLA .65 .60 .62 .49 .42 .55 .82 ATP 1.03 1.13 .93 1.04 1.60 1.29 1.35 KLA/ATP .66 .70 .50 .57 .84 .86 .88 Npc2 KLA  ATP  ATP+KLA NM_023409 Niemann Pick type C2 (Npc2), mRNA [NM_023409] KLA 1.43 1.31 1.36 1.36 1.76 1.85 1.93 ATP 1.18 1.23 .85 1.05 1.11 1.40 2.85 KLA/ATP 1.29 1.46 1.33 1.76 1.46 1.72 4.12 Ppt1 KLA  ATP  ATP+KLA AK148314 B16 F10Y cells cDNA, RIKEN full-length enriched library, clone:G370087F11 product:palmitoyl-protein thioesterase 1, full insert sequence. [AK148314] KLA .81 .79 .79 .90 .82 .88 1.24 ATP .98 1.11 1.72 1.24 1.13 .95 1.91 KLA/ATP .80 .85 1.14 .98 .93 .73 1.39 Ppt1 KLA  ATP  ATP+KLA NM_008917 palmitoyl-protein thioesterase 1 (Ppt1), mRNA [NM_008917] KLA .88 .86 .86 .89 .78 .73 .81 ATP 1.05 1.02 1.17 1.10 .99 .76 .77 KLA/ATP .83 .85 1.02 .91 .71 .59 .71 Ppt2 KLA  ATP  ATP+KLA NM_019441 palmitoyl-protein thioesterase 2 (Ppt2), mRNA [NM_019441] KLA 1.08 1.27 1.22 1.04 1.29 1.14 1.70 ATP 1.13 1.21 .63 .82 .60 .74 1.42 KLA/ATP 1.42 1.32 .63 1.02 .54 .85 2.24 Psap KLA  ATP  ATP+KLA NM_011179 prosaposin (Psap), mRNA [NM_011179] KLA .76 .85 1.08 .72 .90 1.00 1.44 ATP 1.04 1.19 .89 .80 .88 .83 1.46 KLA/ATP .92 .99 .74 .72 .83 1.11 1.68 Psapl1 KLA  ATP  ATP+KLA NM_175249 prosaposin-like 1 (Psapl1), mRNA [NM_175249] KLA .97 .92 .99 1.02 1.07 .97 .88 ATP 1.00 .95 1.08 .99 .96 .88 1.06 KLA/ATP .92 .89 1.06 .95 .92 .94 .85 Scarb2 KLA  ATP  ATP+KLA NM_007644 scavenger receptor class B, member 2 (Scarb2), mRNA [NM_007644] KLA 1.16 1.24 1.23 1.19 1.12 1.09 1.09 ATP .93 .84 .65 .57 .54 .85 1.93 KLA/ATP 1.19 1.05 .85 .86 .74 .86 2.12 Sgsh KLA  ATP  ATP+KLA NM_018822 N-sulfoglucosamine sulfohydrolase (sulfamidase) (Sgsh), mRNA [NM_018822] KLA .68 .66 .65 .65 .54 .61 .71 ATP 1.00 1.03 1.06 .98 .73 .59 .73 KLA/ATP .72 .67 .69 .66 .52 .56 .57 Slc11a1 KLA  ATP  ATP+KLA NM_013612 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 (Slc11a1), mRNA [NM_013612] KLA .69 .70 .70 .66 .98 1.43 2.68 ATP .99 1.07 .84 .93 .97 1.65 3.01 KLA/ATP .75 .72 .54 .62 .61 1.42 4.71 Slc11a2 KLA  ATP  ATP+KLA AK148276 B16 F10Y cells cDNA, RIKEN full-length enriched library, clone:G370074D17 product:solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2, full insert sequence [AK148276] KLA 4.68 4.47 5.11 5.84 7.80 4.69 3.36 ATP 1.10 1.31 1.75 2.78 4.90 3.41 2.70 KLA/ATP 4.73 4.82 5.48 5.26 3.72 3.15 3.67 Slc11a2 KLA  ATP  ATP+KLA NM_008732 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 (Slc11a2), mRNA [NM_008732] KLA 2.46 2.36 2.40 2.57 2.87 2.63 1.86 ATP 1.00 1.01 1.05 1.54 2.27 1.88 1.08 KLA/ATP 2.41 2.15 2.32 2.50 2.87 2.33 1.61 Slc17a5 KLA  ATP  ATP+KLA NM_172773 solute carrier family 17 (anion/sugar transporter), member 5 (Slc17a5), mRNA [NM_172773] KLA .58 .58 .58 .49 .50 .56 .55 ATP 1.21 1.07 1.00 .88 .97 .46 .75 KLA/ATP .67 .61 .60 .55 .67 .47 .51 Smpd1 KLA  ATP  ATP+KLA NM_011421 sphingomyelin phosphodiesterase 1, acid lysosomal (Smpd1), mRNA [NM_011421] KLA .68 .66 .67 .87 .91 1.01 1.11 ATP 1.04 1.02 1.06 1.03 1.02 1.30 1.73 KLA/ATP .69 .68 .86 .71 .78 .99 1.64 Sort1 KLA  ATP  ATP+KLA NM_019972 sortilin 1 (Sort1), mRNA [NM_019972] KLA .94 .96 .92 .94 .74 .58 .38 ATP 1.00 1.01 1.23 1.12 .90 1.04 .77 KLA/ATP .94 .96 1.03 .99 .79 .78 .57 Sumf1 KLA  ATP  ATP+KLA NM_145937 sulfatase modifying factor 1 (Sumf1), mRNA [NM_145937] KLA .91 .99 .86 .99 .87 1.05 1.12 ATP .89 .93 .84 .74 .70 .72 .93 KLA/ATP .90 .88 .85 .71 .71 .90 .90 Tcirg1 KLA  ATP  ATP+KLA NM_016921 T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 (Tcirg1), mRNA [NM_016921] KLA 1.32 1.42 1.49 1.38 1.94 2.26 1.98 ATP 1.01 1.16 .69 .96 1.24 1.32 2.03 KLA/ATP 1.50 1.58 .90 1.29 1.37 2.08 3.28 Tpp1 KLA  ATP  ATP+KLA NM_009906 tripeptidyl peptidase I (Tpp1), mRNA [NM_009906] KLA .80 .82 .82 .72 .69 .67 .69 ATP 1.00 1.10 .95 1.07 .97 .85 1.13 KLA/ATP .86 .87 .70 .87 .76 .75 .81